Dr. Kashiwagi is a physician scientist who possesses a broad and unique skill set for basic and translational research in the field of bioimaging, immunology, cancer biology and laser medicine. He grew up in Nagano, Japan, where he developed an early interest in science, and was fascinated by living creatures, especially insects. He decided to go to medical school and obtained his MD degree at Keio University in Tokyo, Japan in 1997. After finishing his residency in Obstetrics and Gynecology and taking care of more than 1,000 childbirths, he started his research career at Keio University Graduate School of Medicine in Tokyo. Dr. Kashiwagi obtained his PhD in the field of biochemistry in 2004. Although he enjoyed practicing medicine, he was also interested in research and took the advice of his boss in Tokyo to come to the United States to do a postdoctoral fellowship. His postdoctoral training was in the Department of Radiation Oncology, Cardiovascular Research Center and Division of Infectious Diseases at Massachusetts General Hospital studying tumor angiogenesis, nitric oxide biology and immunology. In 2018, he joined the BENMD and started working on the molecular immunoimaging project. His group’s central focus has been to develop a new imaging technology to dissect the immune response in the context of cancer, allergy and infectious diseases with an ultimate goal to translate the knowledge to the clinical practice. They are also working to establishing safe, effective, simple, and affordable immunotherapy for infectious diseases, allergy, autoimmune diseases and cancer using the near-infrared laser technology. With his broad background, he is poised to create a synergy of interdisciplinary collaboration between imaging technology and immunotherapy.